XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
238 hedge funds and large institutions have $6.08B invested in Acceleron Pharma in 2020 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 98 increasing their positions, 71 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 49
2% less funds holding
Funds holding: 242 → 238 (-4)
Holders
238
Holding in Top 10
5
Calls
$22.6M
Puts
$15.3M
Top Buyers
| 1 | +$201M | |
| 2 | +$85.1M | |
| 3 | +$82.7M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$56.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$55.5M |
Top Sellers
| 1 | -$207M | |
| 2 | -$50M | |
| 3 | -$18.1M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$17.8M |
| 5 |
Two Sigma Investments
New York
|
-$16.3M |